Why the study?
Does phleomycin reduce the infectivity of poliovirus and its RNA in HeLa cells?
Does phleomycin reduce the infectivity of poliovirus and its RNA in HeLa cells?
Phleomycin inactivates single-stranded poliovirus RNA and interferes with cellular functions necessary for virus replication, but does not affect intact poliovirus.
Answers are grounded in this paper and cite their sources.
Phleomycin's selective RNA inactivation cautions against direct antiviral use on intact poliovirus; leaves open mechanistic studies on nucleic acid targeting.
The infectivity of intact poliovirus was not affected by exposure to the antibiotic phleomycin at concentrations as high as 200 mug/ml, whereas that of the singlestranded poliovirus ribonucleic acid (RNA) was inactivated to 99% by pretreatment of the RNA with phleomycin at a concentration of 2 mug/ml. The infectivity of double and multistranded RNA was 10 times less sensitive than that of singlestranded RNA to the action of this antibiotic. Preincubation of HeLa cells for 30 min with 10 to 50 mug of phleomycin reduced the sensitivity of the cells to infection by viral RNA and intact virus, indicating that phleomycin interferes with cellular functions necessary for virus replication. When phleomycin was added to cells at different times after infection with single- or double-stranded RNA, the highest inactivation of infective centers was observed immediately after infection. With time of incubation at 37 C, the infective centers became more resistant to the action of phleomycin.
No takes yet. Share an insight, caveat, or question.
Gebhard Koch (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: